Silmag Córdoba expands its biomedical business: opens in Mexico and acquires a company in Brazil

Silmag, an SME from Las Higueras specialized in medical devices, has completed its entry into Mexico and the acquisition of 100% of Total Medical Brasil. These operations consolidate its regional expansion strategy in key markets. With more than 200 employees, the company aims to lead innovation in neonatology and pediatrics.

The new company in Mexico will allow for improved logistics, strengthened exports, and participation in both public and private tenders. Additionally, the company won a tender from the Mexican Social Security Institute (IMSS) to supply devices during 2025 and 2026. Among the awarded products is Silport, recognized in oncology treatments for its quality and safety.

The company considers this award a milestone in its internationalization, positioning Córdoba as an export hub for biomedical innovation. With a strategic vision, Silmag is reinforcing its presence in a market with high growth potential.

Brazil, a firm step in the region

Meanwhile, Silmag moved forward with the acquisition of 100% of Total Medical Brasil, consolidating management control in a strategic market. The operation will allow it to integrate capabilities, optimize processes, and increase competitiveness in the biomedical sector. According to Fernando Gaido, general manager, Brazil offers active industrial policies and a favorable environment for development.

The decision aims to consolidate an efficient and high-quality production model in a key country for the health sector in South America. With this move, the Córdoba-based company secures a greater role in an expanding regional landscape. Silmag thus strengthens its plan for sustainable growth over time.

Support from previous investments enabled it to expand its production capacity and create a solid foundation for these advances. The business commitment reflects the value of private investment for development.

From auto parts manufacturer to biomedical leader

Founded more than 30 years ago, Silmag began its journey as an auto parts manufacturer and later made the leap to biomedical production. Today, it manufactures silicone and polyurethane devices in a 3,500 m² (37,674 square feet) plant in Las Higueras, Córdoba. Its production supplies neonatology, pediatrics, respiratory and urinary tracts, and vascular access.

Currently, 45% of its production is destined for exports reaching more than 15 countries in America, Africa, and Asia. The SME also keeps offices in Río Cuarto, Córdoba capital, and Buenos Aires. Additionally, it invested more than $170 million to increase its manufacturing volume by 50%.

With the new operations in Mexico and Brazil, Silmag reaffirms its role as a regional leader. From the interior of Córdoba, it projects innovation and quality to the world, consolidating an expansion strategy that reflects competitiveness and private initiative.